Sorry, you need to enable JavaScript to visit this website.

Study for continued access to dacomitinib for patients previously treated with dacomitinib in clinical studies in Japan

Treatment Access Protocol for Patients Previously Treated With Dacomitinib on a Clinical Trial in Japan

Category & Conditions: Cancer
Medicine: VIZIMPRO® TABLETS(DACOMITINIB) Identifier (NCT): NCT02382796
Protocol ID: A7471055
Open Plain Language Summary Result: Click here